3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Classical hematology
1
Conditions
Thrombocytopenia
1
Interventions
eltrombopag
8
romiplostim
5
Cytarabine
4
Filgrastim
3
Etoposide
3
Daunorubicin
3
Carboplatin
3
oprelvekin
2
fludarabine phosphate
2
avatrombopag
2
Thrombopoietin
2
Radiotherapy
2
Peripheral Blood Stem Cell Transplantation
2
Lenalidomide
2
Interleukin-11
2
Ifosfamide
2
Doxorubicin
2
Cyclosporine
2
Busulfan
2
sargramostim
1
ofatumumab
1
lusutrombopag
1
leridistim
1
bryostatin 1
1
angiotensin I (1-7)
1
alvocidib
1
Vitamin E
1
Vitamin B 12
1
Vincristine
1
Tranexamic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thrombocytopenia
×
lusutrombopag
×
Clear all
NCT02389621
2018-10-30
L-PLUS 2
Shionogi Inc.
Phase 3
Completed
215 enrolled
24 charts
1 FDA